HOME >> MEDICINE >> NEWS
Bone mass continues to increase in liver transplant patients, despite early loss

A new study on bone loss in patients with liver disease before and after transplant found that those with the lowest bone density before transplant showed the most improvement afterwards. It also showed that bone loss immediately following transplant was common and identified several risk factors for post-transplant bone loss.

The results of this study appear in the September 2006 issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS). The journal is published on behalf of the societies by John Wiley & Sons, Inc. and is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/livertransplantation.

Osteoporosis and osteopenia, its less severe form, are known complications of cirrhosis, especially in patients with cholestatic liver disease (where bile production stops). However, the underlying mechanism of bone loss in these patients is poorly understood and osteoporosis is often overshadowed by the more pressing health problems seen with liver disease. Early aggressive bone loss occurs in almost all patients following transplant, and although immunosuppression is assumed to play a role in bone loss, risk factors have not been well established to date.

In the largest cohort of patients reported to date that were transplanted at a single center, Maureen M. J. Guichelaar of the Division of Gastroenterology and Hepatology at the Mayo Clinic in Rochester, MN and her colleagues studied 360 adult patients undergoing liver transplants at the Mayo Clinic between 1985 and 2001. All of the patients were diagnosed either with end-stage primary biliary cirrhosis (PBC) or primary sclerosing cholangitis (PSC), where the bile ducts become inflamed and obstructed, causing bile to build up in the liver and damage it. Patients
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
5-Sep-2006


Page: 1 2 3

Related medicine news :

1. New update of international health system comparisons: US continues to lag on most measures
2. Prevalence of overweight children, teens and men in US continues to rise
3. Oxford Immunotec welcomes UK NICE guideline on tuberculosis as disease incidence continues to rise
4. Total cholesterol level among US adults continues to decline
5. Inappropriate prescribing of antibiotics by NPs and MDs continues
6. US cancer mortality continues decline but incidence rises slightly for women
7. Traditional Chinese exercises may increase efficacy of flu vaccine
8. Smoking may strongly increase long-term risk of eye disease
9. Diets high in choline may increase risk for colorectal polyps
10. Chemotherapy with bevacizumab increases risk of blood clots in arteries
11. Low hospital staff levels increase infection rates

Post Your Comments:
(Date:5/20/2013)... comprised over 24,000 Finnish subjects and was led ... a panel of 28 genetic markers improved detection ... disease (CHD) (10-year risk ≥20%) over traditional risk ... important preventive strategy for CHD, because the current ... "The results indicate that genetic markers could be ...
(Date:5/20/2013)... 32nd ESTRO European Cancer Congress will take place ... from Friday 17 September to Tuesday 1 October 2013. ... congress will build on the success of the previous ... Oncology) and ESTRO (European Society for Therapeutic Radiology and ... Europe to offer presentations of cutting-edge research across the ...
(Date:5/20/2013)... FL (PRWEB) May 20, 2013 The producers ... segment dedicated to the essentials of home schooling. It will ... teachers will need to assist children in reaching educational goals. ... the most basic needs in education. Instructors can send tests ... connection to the Web. The celebrity-hosted segment is a top-notch ...
(Date:5/20/2013)... George Town, Grand Cayman, Cayman Islands (PRWEB) May ... City , a knowledge-based, high tech Special Economic ... launch of its Referral Network, an initiative to ... unique concessions combined with Cayman’s business-friendly environment and ... around the world, many of them referrals from ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Dr. Fanny J ... Brilliant, a gentle fractional laser treatment clinically proven to fight ... Clear + Brilliant are designed to prevent and ... + Brilliant can visibly illuminate skin tone, renew and smoothen ... skin, and reduce the appearance of pores. Developed by the ...
Breaking Medicine News(10 mins):Health News:Media registration for the European Cancer Congress 2Health News:Editions TV Presents a Home School Essentials Segment 2Health News:Cayman Enterprise City Introduces Referral Network 2Health News:Cayman Enterprise City Introduces Referral Network 3Health News:Delaware Dermatologist Now Offers Clear + Brilliant Gentle Laser Skin Rejuvenation Treatments 2
(Date:5/20/2013)... CLEVELAND , May 20, 2013 ... the healthcare industry by creating the Multi-Disciplinary Clinical ... a variety of medical experts with diverse healthcare ... the healthcare industry to create new software solutions ... the specific needs of patients and staff. ...
(Date:5/20/2013)... Enrollment of patients with Type 2 diabetes ... trial of product candidate NewMet ™, a delayed-release ... 2 diabetes. Elcelyx expects to complete enrollment of 240 ... of the trial,s primary endpoint of change in fasting ... read-out for long-term glucose lowering and weight benefits is ...
(Date:5/20/2013)... 2013  Rhythm announced today the presentation of results ... of gastroparesis symptoms among diabetic patients in the U.S. ... among patients with both type 1 and type 2 ... with the more common type 2 disease. ... Associate Professor of Medicine at Harvard Medical School and ...
Breaking Medicine Technology:Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4
Cached News: